Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Skin extracellular matrix hydration" is not a discrete molecular target suitable for drug development. Instead, it describes a physiological property or functional outcome of the extracellular matrix (ECM) in skin. Skin hydration is a consequence of specific ECM components, not a target itself. The actual molecular components involved in ECM hydration include proteoglycans and glycosaminoglycans (GAGs), which regulate hydration primarily through their negative charge, attracting sodium ions and subsequently water molecules via osmosis. Key molecules contributing to this process are hyaluronic acid (a chief component of the interstitial gel), versican, decorin, and other glycosaminoglycans. Therapeutic targeting would involve specific molecular components like ECM proteins (e.g., hyaluronic acid, collagen types), enzymes regulating ECM composition (e.g., matrix metalloproteinases, lysyl oxidase), cell surface receptors mediating ECM interactions (e.g., CD44, integrins), or growth factor signaling pathways regulating ECM synthesis (e.g., TGF-β pathway).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin extracellular matrix hydration.